L3VLUP
ProSign in

UTHR in the 13F filings

United Therapeutics Corp Del · CUSIP 91307C102

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
30 Jun 2024
the date the book describes
Filed
15 Aug 2024
latest of these filings; the earliest 6 Aug 2024
Managers listing it
14
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q1 2024 and Q2 2024; 11 listed it in both
Shares listed
7,861,406
combined, among listed positions
Reported value
$2.5bn
combined, at the quarter end

Among the 94 comparable managers: 8 buyers (opened or added shares) and 7 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing UTHR in Q2 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

14 of 14 holders

ActionFiling
Wellington Management Group LLP3,285,289$1.0bn0.19%Trimmed-126,97114 Aug 2024 (the filing on sec.gov)
Renaissance Technologies LLC2,174,692$693m1.17%Added+22,9789 Aug 2024 (the filing on sec.gov)
AQR Capital Management LLC719,510$229m0.35%Trimmed-127,44514 Aug 2024 (the filing on sec.gov)
AllianceBernstein LP539,617$172m0.06%Added+66,33214 Aug 2024 (the filing on sec.gov)
Arrowstreet Capital LP438,684$140m0.12%Added+340,73514 Aug 2024 (the filing on sec.gov)
Janus Henderson Group Ltd410,010$131m0.07%Trimmed-225,33714 Aug 2024 (the filing on sec.gov)
Farallon Capital Management LLC143,000$46m0.20%Added+33,00014 Aug 2024 (the filing on sec.gov)
Man Group PLC75,319$24m0.06%Trimmed-31,20214 Aug 2024 (the filing on sec.gov)
Acadian Asset Management LLC22,590$7.2munder 0.1%Trimmed-89,3666 Aug 2024 (the filing on sec.gov)
Schonfeld Strategic Advisors LLC20,522$6.5munder 0.1%Trimmed-65,10114 Aug 2024 (the filing on sec.gov)
Bridgewater Associates LP12,752$4.1munder 0.1%Addedn.a.14 Aug 2024 (the filing on sec.gov)
Caxton Associates LLP9,352$3.0m0.10%Newnew14 Aug 2024 (the filing on sec.gov)
PDT Partners LLC6,540$2.1m0.20%Added+70015 Aug 2024 (the filing on sec.gov)
Brevan Howard Capital Management LP3,529$1.1munder 0.1%Newnew14 Aug 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2024 to Q2 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (2)

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
10 in Q3 2024 to 14 in Q2 2026

Tracked managers listing it, at least.

051015202014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
UTHR by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20135$378mn.a.n.a.
Q3 20135$587mn.a.n.a.
Q4 20139$1.1bnn.a.n.a.
Q1 20148$923mn.a.n.a.
Q2 20149$716mn.a.n.a.
Q3 201411$1.1bnn.a.n.a.
Q4 201410$1.2bnn.a.n.a.
Q1 201514$1.6bnn.a.n.a.
Q2 201514$1.6bnn.a.n.a.
Q3 201516$1.3bnn.a.n.a.
Q4 201516$1.6bnn.a.n.a.
Q1 201617$1.1bnn.a.n.a.
Q2 201612$869mn.a.n.a.
Q3 201614$1.0bnn.a.n.a.
Q4 201610$1.1bnn.a.n.a.
Q1 201713$1.1bnn.a.n.a.
Q2 201712$1.2bnn.a.n.a.
Q3 20178$1.1bnn.a.n.a.
Q4 201710$1.4bnn.a.n.a.
Q1 20188$1.0bnn.a.n.a.
Q2 201810$996mn.a.n.a.
Q3 20189$1.1bnn.a.n.a.
Q4 20189$1.0bnn.a.n.a.
Q1 20199$1.1bnn.a.n.a.
Q2 201915$804mn.a.n.a.
Q3 201917$913mn.a.n.a.
Q4 201914$863mn.a.n.a.
Q1 202014$1.2bnn.a.n.a.
Q2 202014$1.4bnn.a.n.a.
Q3 202010$797mn.a.n.a.
Q4 202011$1.2bnn.a.n.a.
Q1 202110$1.4bnn.a.n.a.
Q2 202111$1.5bnn.a.n.a.
Q3 202116$1.5bnn.a.n.a.
Q4 202114$1.9bnn.a.n.a.
Q1 202214$1.7bnn.a.n.a.
Q2 202218$2.3bnn.a.n.a.
Q3 202217$2.2bnn.a.n.a.
Q4 202218$2.9bnn.a.n.a.
Q1 202316$2.5bnn.a.n.a.
Q2 202312$2.5bnn.a.n.a.
Q3 202313$2.4bnn.a.n.a.
Q4 202314$2.3bn86
Q1 202419$2.2bn146
Q2 202414$2.5bn87
Q3 202410$2.9bn64
Q4 202414$3.3bn84
Q1 202514$2.1bn76
Q2 202514$1.9bn95
Q3 202516$2.6bn810
Q4 202514$3.8bn1720
Q1 202618$5.1bn1817
Q2 202614$3.5bn1916

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

UTHR and LLY →UTHR and JNJ →UTHR and VRTX →Choose a stock to compare with UTHR →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own UTHR, latest filings →Back to the 13F Explorer →